Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.45 |
| ▸ | BAD | Q92934 | 1/20 | 0.45 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1206454 | 0.80 | KMT2A (0.45) | ALDH1A1SMN1; SMN2LMNAMAPK1RAB9A | |
| SCHEMBL9901869 | 0.80 | PARP1 (0.41) | TSHRCA1CA2ALDH1A1SMN1; SMN2 | |
| SCHEMBL578580 | 0.76 | TSHR (0.52) | TSHRTP53BCL2L1BADSRD5A2 | |
| SCHEMBL2780243 | 0.74 | TSHR (0.50) | TSHRTP53BCL2L1BADSRD5A2 | |
| SCHEMBL1869090 | 0.73 | ALDH1A1 (0.50) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL4957915 | 0.73 | TSHR (0.48) | TSHRTP53BCL2L1BADSRD5A2 | |
| SCHEMBL6631569 | 0.73 | TSHR (0.48) | TSHRTP53SRD5A2CA1CA2 | |
| Terephthalic Acid SCHEMBL175823 | 0.68 | TSHR (1.00) | TSHRTP53BCL2L1BADSRD5A2 | |
| Terephthalic Acid SCHEMBL1655 | 0.68 | TSHR (1.00) | TSHRTP53BCL2L1BADSRD5A2 | |
| Terephthalic Acid SCHEMBL5053781 | 0.68 | TSHR (1.00) | TSHRTP53BCL2L1BADSRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101611019-A | The big ring serum prothrombin conversion accelerator (SPCA) a inhibitor that can be used as anticoagulant | BRISTOL MYERS SQUIBB CO (US) | 2009-12-23 | — | — | CN | claimed |
| US-20170174676-A1 | CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2017-06-22 | — | — | US | disclosed |
| US-9512354-B2 | Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics | BASF SE (DE) | 2016-12-06 | — | — | US | disclosed |
| EP-2181172-B1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2016-02-24 | — | — | EP | disclosed |
| US-20140155603-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2014-06-05 | — | — | US | disclosed |
| US-8674104-B2 | Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof | BASF SE (DE) | 2014-03-18 | — | — | US | disclosed |
| US-8592806-B2 | Quinone compounds as dopants in organic electronics | NOVALED AG (DE) | 2013-11-26 | — | — | US | disclosed |
| EP-2401254-B1 | QUINONE COMPOUNDS AS DOPANTS IN ORGANIC ELECTRONICS | NOVALED AG (DE) | 2013-06-19 | — | — | EP | disclosed |
| US-20130123495-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | CLAP CO., LTD. (KR) | 2013-05-16 | — | — | US | disclosed |
| US-20120217483-A1 | Quinone Compounds as Dopants in Organic Electronics | NOVALED AG (DE) | 2012-08-30 | — | — | US | disclosed |
| US-20110068328-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2011-03-24 | — | — | US | disclosed |
| EP-2297274-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2011-03-23 | — | — | EP | disclosed |
| WO-2010097433-A1 | QUINONE COMPOUNDS AS DOPANTS IN ORGANIC ELECTRONICS | BASF SE (DE) | 2010-09-02 | — | — | WO | disclosed |
| CN-101809116-A | Halogen-containing perylene tetracarboxylic acid derivatives and uses thereof | BASF SE | 2010-08-18 | — | — | CN | disclosed |
| EP-2181172-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2010-05-05 | — | — | EP | disclosed |
| CN-101611019-A | The big ring serum prothrombin conversion accelerator (SPCA) a inhibitor that can be used as anticoagulant | BRISTOL MYERS SQUIBB CO (US) | 2009-12-23 | — | — | CN | disclosed |
| WO-2009147237-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2009-12-10 | — | — | WO | disclosed |
| US-20090301552-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2009-12-10 | — | — | US | disclosed |
| WO-2009024512-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2009-02-26 | — | — | WO | disclosed |
| WO-2009000831-A1 | BROMINE-SUBSTITUTED RYLENE TETRACARBOXYLIC ACID DERIVATIVES, AND THE USE THEREOF | BASF SE (DE) | 2008-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120217483-A1 | Quinone Compounds as Dopants in Organic Electronics | NQO1, DDT, COMT | TSHR 4760/4885TP53 1856/4885BCL2L1 4046/4885 |
| US-20090301552-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | SLCO2A1, SLCO4C1, SLCO2B1 | TSHR 1100/4885TP53 585/4885BCL2L1 3612/4885 |
| US-20110068328-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | NR0B1, NR0B2, RXRB | TSHR 357/4885TP53 3727/4885BCL2L1 2578/4885 |
| US-20170174676-A1 | CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | SLCO2A1, SLCO2B1, SLC43A3 | TSHR 1739/4885TP53 1826/4885BCL2L1 4194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.